Krajina: Írsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
ANASTROZOLE
Profind Wholesale Ltd.
1 Milligram
Film Coated Tablet
2010-10-29
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Arimidex 1mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 1 mg anastrozole. Excipients: also contains lactose monohydrate For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film-coated tablet. _Product imported from the UK and Italy:_ White, biconvex tablet with a logo on one side and marked 'Adx 1' on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of early breast cancer in postmenopausal women who are hormone-receptor positive. Treatment of advanced breast cancer in postmenopausal women. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults includes the elderly: One 1mg tablet to be taken orally once a day. Children: Arimidex is not recommended for use in children due to insufficient data on safety and efficacy (_see sections 4.4 and_ _5.1)._ Renal Impairment: No dose change is recommended. Hepatic Impairment: No dose change is recommended. 4.3 CONTRAINDICATIONS Arimidex must not be administered during pregnancy or lactation. Patients with known hypersensitivity to anastrozole or to any of the excipients referenced in _Section 6.1._ 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Arimidex is not recommended for use in children or in premenopausal women as safety and efficacy have not been established in these groups of patients _(see sections 5.1)._ IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 13/05/2011_ _CRN 2097343_ _page number: 1_ Arimidex should not be used in boys with growth hormone deficiency in addition to growth hormone treatment. In the pivotal clinical trial, efficacy was not demonstrated and safety was not established _(see Prečítajte si celý dokument